Alarelin Acetate是一种合成的促性腺激素释放激素激动剂。
Cas No.:79561-22-1
Sample solution is provided at 25 µL, 10mM.
Alarelin Acetate is a synthetic gonadotropin-releasing hormone (GnRH) agonist[1-2]. During the initial phase of administration, Alarelin Acetate stimulates the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and is utilized in research related to conditions such as endometriosis, uterine fibroids, and infertility caused by ovarian dysfunction[3-4].
In vitro, treatment of rat gastric parietal cells with Alarelin Acetate (1μM) for 24 hours, Alarelin Acetate inhibited gastric acid secretion by acting on GnRH receptors on parietal cells, and reduced gastric acid secretion by suppressing vagal nerve activity, with effects exhibiting time-dependent characteristics[5]. Treatment of rat gastric smooth muscle cells with Alarelin Acetate (1nM–10μM) for 24–48 hours, Alarelin Acetate significantly inhibited cell proliferation activity and DNA synthesis via GnRH receptors, arrested the cell cycle in the G1 phase and reduced the proportion of cells in the S phase[6].
In vivo, administration of Alarelin Acetate via a PLGA microsphere sustained-release system (35μg/kg or 200μg/kg) as a single intramuscular injection in Acipenser ruthenus(with sampling at 24, 48, and 72 hours), Alarelin Acetate effectively induced spermiation, prolonged semen collection duration, and enhanced sperm motility at the 35μg/kg dose[7]. In non-breeding season Assaf and Lacaune ewes, intramuscular injection of Alarelin Acetate (7.5μg) combined with progesterone (37.5mg) on day 0 of the experiment, Alarelin Acetate increased lambing rate, improved reproductive performance, and enhanced fertility[8].
References:
[1] Yuan F, Zhang P, Liu M, et al. Pharmacogenomic analysis of alarelin acetate-induced hepatotoxicity: a case report and literature review. Front Med (Lausanne). 2025 Sep 29;12:1634101.
[2] Chu L, Terasaki M, Mattsson CL, et al. In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system. Cell Chem Biol. 2022 Sep 15;29(9):1368-1380.e5.
[3] Kong Y, Zhang JW. Experimental study on rat model of endometriosis treated with tamoxifen and rhizoma curcumae oil. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Jul;37(4):596-8.
[4] Zhang K, Gao G, Zhao X, et al. The direct effects of gonadotropin-releasing hormone on proliferation of granulosa cells and development of follicles in goose. Br Poult Sci. 2020 Jun;61(3):242-250.
[5] Chen L, Sun XD, Zhao J, et al. Distribution, cloning and sequencing of GnRH, its receptor, and effects of gastric acid secretion of GnRH analogue in gastric parietal cells of rats. Life Sci. 2005 Feb 4;76(12):1351-65.
[6] Chen L, He HX, Sun XD, et al. Expression of gonadotropin-releasing hormone receptor and effect of gonadotropin-releasing hormone analogue on proliferation of cultured gastric smooth muscle cells of rats. World J Gastroenterol. 2004 Jun 15;10(12):1780-4.
[7] Podhorec P, Knowles J, Vysloužil J, et al. Induction of Spermiation in Sterlet Acipenser ruthenus by PLGA Microparticle Delivery with Sustained Alarelin Release. Animals (Basel). 2021 Nov 19;11(11):3305.
[8] Alijani A, Niasari-Naslaji A, Sayyah N, et al. Comparing CIDR with progesterone injections and eCG with human recombinant FSH for synchronizing estrous cycle in ewes. Iran J Vet Res. 2024;25(1):3-7.
Alarelin Acetate是一种合成的促性腺激素释放激素激动剂[1-2]。Alarelin Acetate在用药初期可刺激垂体释放促黄体生成素和促卵泡素,Alarelin Acetate可用于子宫内膜异位症、子宫肌瘤及卵巢功能异常引起的不孕症等相关研究[3-4]。
在体外,Alarelin Acetate(1μM)处理大鼠胃壁细胞24小时,Alarelin Acetate通过作用于壁细胞上的GnRH受体直接抑制胃酸分泌,并可能通过抑制迷走神经功能间接降低胃酸分泌,作用呈时间依赖性[5]。Alarelin Acetate(1nM-10μM)处理大鼠胃平滑肌细胞24-48小时,Alarelin Acetate通过GnRH受体显著抑制细胞增殖活力、DNA合成,同时将细胞周期阻滞在G1期并减少S期比例[6]。
在体内,Alarelin Acetate通过PLGA微球缓释系统(35μg/kg或200μg/kg)单次肌肉注射处理Acipenser ruthenus(于24、48和72小时采样),35μg/kg Alarelin Acetate可有效诱导Acipenser ruthenus排精,延长精液采集时间,并提高精子活力[7]。Alarelin Acetate(7.5μg)联合孕酮(37.5mg)在实验第0天肌肉注射处理非繁殖季节的Assaf和Lacaune母羊,Alarelin Acetate可增加母羊的产羔率、繁殖力和生育力[8]。
| Cell experiment [1]: | |
Cell lines | Sprague-Dawley rats gastric smooth muscle cells (GSMCs) |
Preparation Method | GSMCs were isolated via collagenase I digestion and maintained in DMEM supplemented with 10% calf serum at 37°C under 5% CO₂. Cells were treated with Alarelin Acetate at concentrations of 10nM, 100nM, and 10μM for 24 hours. |
Reaction Conditions | 10nM, 100nM, and 10μM; 24h |
Applications | Alarelin Acetate significantly inhibited GSMC proliferation in a dose-dependent manner. Alarelin increased G1-phase cell proportion and reduced S-phase cells, indicating cell cycle arrest at G1/S phase. The effects were mediated through GnRH receptors expressed in GSMC cytoplasm. |
| Animal experiment [2]: | |
Animal models | Male sterlet (Acipenser ruthenus) |
Preparation Method | Fish were acclimatized to 15°C water temperature and received a single intramuscular injection of PLGA microparticles encapsulating Alarelin Acetate (35µg/kg or 200µg/kg) suspended in saline. Blood and milt samples were collected at 24-, 48-, and 72-hours post-injection for analysis of androgens and sperm parameters. |
Dosage form | 35µg/kg or 200µg/kg; i.m.; Single injection. |
Applications | Alarelin Acetate delivered via PLGA microparticles significantly induced spermiation, increased plasma testosterone and 11-ketotestosterone levels, and prolonged sperm production over 72 hours. The 35µg/kg dose achieved optimal sperm motility and relative sperm production, comparable to carp pituitary extract, while the 200µg/kg dose resulted in lower initial sperm concentration but sustained output. |
References: | |
| Cas No. | 79561-22-1 | SDF | |
| 别名 | 醋酸阿拉瑞林,Alarelin | ||
| 化学名 | acetic acid compound with (Z)-N-((6S,7Z,9S,10Z,12R,13Z,15S,16Z,18S,19Z,21S,22Z,24S)-21-((1H-indol-3-yl)methyl)-1-amino-6-((S)-2-((Z)-(ethylimino)(hydroxy)methyl)pyrrolidine-1-carbonyl)-8,11,14,17,20,23-hexahydroxy-15-(4-hydroxybenzyl)-18-(hydroxymethyl)-2 | ||
| Canonical SMILES | CC/N=C(O)/[C@]1([H])CCCN1C([C@](/N=C(O)/[C@](/N=C(O)/[C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/C2([H])CCC(O)=N2)([H])CC3=CN=CN3)([H])CC4=CNC5=CC=CC=C45)([H])CO)([H])CC6=CC=C(O)C=C6)([H])C)([H])CC(C)C)([H])CCCNC(N)=N)=O.CC(O)=O.CC(O | ||
| 分子式 | C60H86N16O16 | 分子量 | 1287.42 |
| 溶解度 | ≥ 128.8mg/mL in Water, ≥ 128.7mg/mL in DMSO, ≥ 128.6mg/mL in EtOH | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 776.7 μL | 3.8837 mL | 7.7675 mL |
| 5 mM | 155.3 μL | 776.7 μL | 1.5535 mL |
| 10 mM | 77.7 μL | 388.4 μL | 776.7 μL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















